Convergent

Convergent Energy and Power Releases 2023 Sustainability and Impact Report

Retrieved on: 
Thursday, March 14, 2024
Other Energy, Professional Services, Environmental Policy, Utilities, Sustainability, Alternative Energy, Energy, Environment, Other Professional Services, Green Technology, Climate Change, Environmental, Social and Governance (ESG), Annual report, Convergent, Biophysical environment, Risk, ESG, Research, Sustainalytics, CO2, Safety, ESS, Renewable energy

Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in North America, today announced the publication of its 2023 Sustainability and Impact Report.

Key Points: 
  • Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in North America, today announced the publication of its 2023 Sustainability and Impact Report.
  • “This report documents our demonstrated leadership in the renewable energy sector but also our commitment to improve in the year ahead.
  • We’re proud to be in the business of accelerating the clean energy transition through AI-powered energy storage.
  • As of April 2023, Sustainalytics rated Convergent as the seventh-lowest risk company out of 706 companies rated within the utilities sector.

City of Hope to Present New Research at the American Association of Cancer Research (AACR) Annual Meeting 2024, Highlighting Promising Data on Prostate, Colorectal and Pancreatic Cancer

Retrieved on: 
Tuesday, March 12, 2024
Research, Other Health, General Health, Pharmaceutical, Oncology, Biometrics, Hospitals, Genetics, Health Technology, Science, Biotechnology, Health, Other Science, Breast cancer, Syngenic, Convergent, Computational biology, Patient, Distinguishing, Beckman Research Institute, City, Tumor microenvironment, PSCA, Haematopoietic system, Memory, AACR, Lymphocyte, Treatment, Convergent Science, Neoplasm, Road, Systems biology, CRC, Division, Microbiome, Hematology, Pharmaceutical industry

To investigate why Hispanic/Latino colorectal cancer (CRC) patients in Los Angeles face mortality rates up to 20% higher than their Caucasian counterparts, City of Hope’s Enrique Velazquez Villarreal, M.D., Ph.D., M.P.H., M.S.

Key Points: 
  • To investigate why Hispanic/Latino colorectal cancer (CRC) patients in Los Angeles face mortality rates up to 20% higher than their Caucasian counterparts, City of Hope’s Enrique Velazquez Villarreal, M.D., Ph.D., M.P.H., M.S.
  • They found that the model was sensitive to microbiome modulation and that the use of patient-derived human fecal matter transfers can significantly impact PSCA-CAR T cell directed anti-tumor responses.
  • , will also chair the inaugural AACR event called From Cancer Discoveries to Patients on April 4 and 5.
  • The event brings together leaders in clinical research, biotech and the investment community as part of AACR’s commitment to expediting the advancement of lifesaving cancer discoveries.

Convergent Research Announces Major New Funding Commitment to Forest Neurotech

Retrieved on: 
Monday, March 11, 2024
Technology, Biotechnology, Health, Venture Capital, Neurology, Professional Services, Philanthropy, Research, Medical Devices, Software, General Health, Fund Raising, Foundation, Science, Citadel, Depression, Brain, BCI, Fro, Convergent, Seizure, FRO, BCIS, Therapy, Multimedia

Convergent Research today announced a new $14 million funding commitment from former Google CEO Eric Schmidt to Forest Neurotech , an initiative designed to create next-generation brain-computer-interfaces (BCIs) for individuals with neurological injuries or diseases.

Key Points: 
  • Convergent Research today announced a new $14 million funding commitment from former Google CEO Eric Schmidt to Forest Neurotech , an initiative designed to create next-generation brain-computer-interfaces (BCIs) for individuals with neurological injuries or diseases.
  • FROs are an innovative funding structure pioneered by Convergent Research , to support moonshot efforts that create new scientific tools and datasets.
  • Forest's state-of-the-art tools, research, and discoveries will be shared with the broader scientific community, aligning with Convergent Research's commitment to open science.
  • Convergent Research is a 501(c)(3) nonprofit that pioneers the launch of Focused Research Organizations (FROs) to unblock research bottlenecks.

Convergent Therapeutics Announces FDA Clearance of IND Application for CONV01-α, a Best-in-Class Radioantibody Targeting Prostate-Specific Membrane Antigen

Retrieved on: 
Tuesday, April 2, 2024
Radiation, Convergent, Prostate cancer, Patient, IND, Alpha, Therapy, Cancer, Safety, CSO, PSA, FDA, Food, Pharmaceutical industry

CAMBRIDGE, Mass., April 2, 2024 /PRNewswire/ -- Convergent Therapeutics Inc., a clinical stage biotechnology company focused on developing next generation radiopharmaceutical therapies for the treatment of prostate cancer and other cancers, today announced that the U.S. Food and Drug Administration ("FDA") has cleared the investigational new drug ("IND") application for CONV01-α, its lead candidate for the treatment of patients with advanced prostate cancer.

Key Points: 
  • "Receiving clearance of our IND is a significant milestone for Convergent Therapeutics," said Convergent's Co-founder and CEO, Philip Kantoff, MD.
  • "Importantly, patients also showed minimal side effects in Phase 1/2 trials.
  • CONV01-α's ideal biodistribution delivers potent alpha particles while avoiding immediate and significant salivary gland toxicity as well as the potential delayed renal toxicity," said Neil Bander, MD, Convergent's Co-founder and CSO.
  • "CONV01-α's design increases delivery of tumor-killing radiation to malignant cells while greatly reducing both off-tumor effects and the amount of radiation delivered per dose, thereby improving both treatment efficacy and safety."

Anil Goel Named Chief Engineering Officer of Nielsen

Retrieved on: 
Monday, March 18, 2024
Automation, Convergent, Partnership, Byju's, Educational technology, Architecture, Amazon (company), Music

NEW YORK, March 18, 2024 /PRNewswire/ -- Nielsen, the global leader in audience measurement, data and analytics, announced today that Anil Goel has joined Nielsen as the Chief Engineering Officer.

Key Points: 
  • NEW YORK, March 18, 2024 /PRNewswire/ -- Nielsen, the global leader in audience measurement, data and analytics, announced today that Anil Goel has joined Nielsen as the Chief Engineering Officer.
  • As Global Chief Engineering Officer, Goel will lead Nielsen's technology and engineering teams to drive product innovation and advanced technology adoption, working in close partnership with Nielsen's product teams.
  • "I'm thrilled to lead the innovation and adoption of advanced technologies as Nielsen's Chief Engineering Officer," said Goel.
  • "Anil has the vision and experience to lead Nielsen's technology innovation to power a better media future for all people."

Convergent Therapeutics Appoints Scott Myers as Chairman of its Board of Directors

Retrieved on: 
Monday, March 4, 2024
Acquisition, Cancer, Prostate, Entrepreneurship, Therapy, Seagen, ADHD, Convergent, Pharmaceutical industry

CAMBRIDGE, Mass., March 4, 2024 /PRNewswire/ -- Convergent Therapeutics Inc., a clinical stage biotechnology company focused on developing next generation radiopharmaceutical therapies for prostate and other cancers, today announced the appointment of Scott Myers as Chairman of its Board of Directors.

Key Points: 
  • CAMBRIDGE, Mass., March 4, 2024 /PRNewswire/ -- Convergent Therapeutics Inc., a clinical stage biotechnology company focused on developing next generation radiopharmaceutical therapies for prostate and other cancers, today announced the appointment of Scott Myers as Chairman of its Board of Directors.
  • "Speaking on behalf of Convergent's Board of Directors and our leadership team, I am delighted that Scott agreed to join our Board as Chair," said Dr. Philip Kantoff, Co-Founder and CEO of Convergent.
  • Mr. Myers currently serves as the Chairman of the Board of Dynavax Technologies, a commercial stage vaccine company.
  • Mr. Myers also serves as Chairman of the Board of Directors of Ironshore Pharmaceuticals, a private, commercial stage ADHD company.

Netcracker Receives Global Telecoms Award for Advancing 5G Monetization Opportunities for Telcos

Retrieved on: 
Tuesday, January 23, 2024
Data Management, Technology, Telecommunications, Apps, Applications, Software, Artificial Intelligence, Networks, Audio, Video, Internet, Mobile, Wireless, 5G, Revenue management, Convergent, Netcracker Technology, CCS, SVP, Video game

Netcracker Technology announced today that it has received a Global Telecoms (Glotel) Award from Telecoms.com for advancements in 5G monetization.

Key Points: 
  • Netcracker Technology announced today that it has received a Global Telecoms (Glotel) Award from Telecoms.com for advancements in 5G monetization.
  • The award recognizes Netcracker’s efforts in helping communications service providers (CSPs) move beyond connectivity to monetizing quality of service and experiences – such as those provided by partners – and other innovative use cases.
  • “Monetizing 5G remains a significant challenge for the telecom industry,” said Scott Bicheno, Editor of Telecoms.com.
  • “In winning this award for its Convergent Charging System at the recent Glotels, Netcracker has been recognized by its peers as leading the charge towards unlocking the new revenue opportunities of 5G.

Convergent Energy and Power Surpasses 1 GWh of Contracted Energy Storage and Solar-Plus-Storage Systems

Retrieved on: 
Thursday, January 11, 2024
Alternative Energy, Energy, Other Energy, Utilities, Entrepreneurship, Weather, Electricity, Climate change, Urbanization, Convergent, Wind, United, Ageing, Renewable energy

Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in North America, announced today that it has over 800 MW / 1 GWh of energy storage and solar-plus-storage systems operating or under development, which is equivalent to the power consumed by approximately 750,000 homes.

Key Points: 
  • Convergent Energy and Power (Convergent), a leading provider of energy storage solutions in North America, announced today that it has over 800 MW / 1 GWh of energy storage and solar-plus-storage systems operating or under development, which is equivalent to the power consumed by approximately 750,000 homes.
  • This milestone represents Convergent’s success since its inception over a decade ago and the growing demand for energy storage worldwide.
  • The energy storage and renewable energy sectors are designed to mitigate the impacts of climate change, advance the clean energy transition, and support the United States’ overextended, aging power infrastructure.
  • Energy storage, especially when paired with solar, is the answer to many of today’s challenges,” said Convergent Energy and Power’s CEO and Co-Founder, Johannes Rittershausen.

Donald J. Jenkins Named Chief Operating Officer at Convergent Energy and Power

Retrieved on: 
Tuesday, December 19, 2023
Other Energy, Utilities, Environment, Sustainability, Alternative Energy, Green Technology, Energy, Destiny of X, Enel, Enel X, United States Navy, Doctor of Philosophy, United States Marine Corps, Senior, ECP, University, Convergent, Face, Growth, Data science, Climate, Global Operations

Convergent Energy and Power (Convergent), a leading provider of energy storage solutions across North America, today announced the appointment of Donald J. Jenkins as Chief Operating Officer.

Key Points: 
  • Convergent Energy and Power (Convergent), a leading provider of energy storage solutions across North America, today announced the appointment of Donald J. Jenkins as Chief Operating Officer.
  • Most recently, Jenkins served as the Chief Operating Officer for Mirah, a software company focused on enabling evidence-based practices in mental healthcare.
  • “I am thrilled to join Convergent Energy and Power because I share the team’s passion for the clean energy transition in the face of the climate crisis,” said Jenkins.
  • Founded in 2011, Convergent is a portfolio company of Energy Capital Partners (ECP), a leading energy transition-focused investor.

EDO Enhances Convergent TV Analytics with Experian Audience Insights

Retrieved on: 
Wednesday, December 13, 2023
Professional Services, Marketing, Advertising, Entertainment, Communications, Data Analytics, TV and Radio, Convergent, Smart TV, Similarweb, The Walt Disney Company, Nielsen, CTV, Partnership, Television, Connected, BET, Netflix, Experian

EDO , the TV outcomes company, and Experian , the world’s leading global information services company, will enrich EDO’s Connected TV (CTV) outcomes data with demographic attributes from Experian for more granular measurement across major leading TV platforms and manufacturers.

Key Points: 
  • EDO , the TV outcomes company, and Experian , the world’s leading global information services company, will enrich EDO’s Connected TV (CTV) outcomes data with demographic attributes from Experian for more granular measurement across major leading TV platforms and manufacturers.
  • EDO’s IdentitySpine™ improves interoperability with data partners and enables deeper consumer behavioral insights for advertisers and leading CTV players.
  • This integration offers EDO clients richer consumer insights, enabling more precision in their approach to their advertising strategies," said Ali Mack, Head of Television and Agency Partnerships, Experian.
  • The announcement follows EDO’s data partnership announcements with Nielsen and Similarweb as part of its goal to drive immediate, actionable insights for Convergent TV advertisers.